Company Atlasby Kadoa
Star on GitHub

Abbott Laboratories ABT

Abbott Laboratories is the 67th largest S&P 500 company by market cap, worth $179 billion. 14 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 10 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 10.4% of the company.

Chair and CEO
Robert B. Ford
Sector
Health Care
Sub-industry
Health Care Equipment
Headquarters
North Chicago, Illinois
Founded
1888
More
Wikipedia
Market cap
$179B
67th largest, 23 Oct 2026 close
Revenue
$44.3B
Fiscal year 2025
Price to sales
4.0
Market cap over revenue
Employees
115,000
10-K, 31 Dec 2025
Market cap per employee
$1.6M
Market cap over employees
Connections
8
S&P 500 companies sharing a director or officer

Largest institutional holders

Each fund group's share of Abbott Laboratories. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 31.4% of Abbott Laboratories.

Source: SEC Form 13F data sets, SEC XBRL shares outstanding 路 All holders

Board and officers

7 people here also hold roles at other S&P 500 companies.

Roles filed up to 30 Sep 2026

NameTitle
Directors (14)
Robert B. FordChairman and CEOChairman and CEO
Nita AhujaDirectorDirector
Robert J. AlpernDirectorAlso at AbbVieDirector
Claire Babineaux-FontenotDirectorDirector
Sally E. BlountDirectorDirector
Kevin T. ConroyDirectorAlso at Align TechnologyDirector
Patricia Paola GonzalezDirectorDirector
Michelle KumbierDirectorAlso at Teledyne TechnologiesDirector
Darren W. McDewDirectorAlso at GE AerospaceDirector
Nancy McKinstryDirectorAlso at Accenture and Mondelez InternationalDirector
Michael O'GradyDirectorAlso at Northern TrustDirector
Michael F. RomanDirectorDirector
Daniel J. StarksDirectorDirector
John G. StrattonDirectorAlso at General DynamicsDirector
Officers (10)
Philip P. BoudreauEVP and CFOLast filed 3 Sep 2026EVP and CFO
Elizabeth C. CushmanEVP, GC and SecretaryLast filed 29 Jun 2026EVP, GC and Secretary
Lisa D. EarnhardtEVP and Group PresidentLast filed 3 Mar 2026EVP and Group President
John A. McCoy Jr.Vice President and ControllerLast filed 3 Sep 2026Vice President and Controller
Mary K. MorelandExecutive Vice PresidentLast filed 29 Apr 2026Executive Vice President
Louis H. MorroneExecutive Vice PresidentLast filed 13 Aug 2026Executive Vice President
Jacob A. OrvilleSenior Vice PresidentLast filed 25 Mar 2026Senior Vice President
Daniel Gesua Sive SalvadoriEVP and Group PresidentLast filed 3 Mar 2026EVP and Group President
Christopher J. ScogginsExecutive Vice PresidentLast filed 3 Mar 2026Executive Vice President
Eric ShroffSenior Vice PresidentLast filed 3 Mar 2026Senior Vice President

Source: SEC insider filings (Forms 3, 4 and 5), Abbott Laboratories' Form 4 filings 路 All directors and officers

Companies that share people with Abbott Laboratories

Each person's title here, then at the other company.

Source: SEC insider filings 路 See the whole network

Abbott Laboratories' market cap since December 2008

Marked weeks are changes in the share count, such as a merger, not market moves.

Weekly, up to 23 Oct 2026

Show equal percentage changes as equal steps.
201020122014201620182020202220242026$179B

Source: Yahoo Finance closing prices, SEC XBRL shares outstanding

Workforce

Headcount at 31 Dec 2025

Employees
115,000
As of December 31, 2025, Abbott employed approximately 115,000 people, 69% of whom were employed outside of the U.S.
Abbott Laboratories Form 10-K

Source: Abbott Laboratories Form 10-K

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 30 Sep 2025 to 30 Sep 2026

Directors and officers sold $47.5 million of stock in 10 sales and bought $4.4 million in 5 purchases in the 12 months to 30 Sep 2026.

DatePersonTitleTypeSharesValue
2 Sep 2026SaleJohn A. McCoy Jr.Vice President and ControllerVice President and ControllerSale27$3K
25 Aug 2026SaleRobert B. FordChairman and CEOChairman and CEOSale398,832$46M
11 Aug 2026SaleLouis H. MorroneExecutive Vice PresidentExecutive Vice PresidentSale5,850$643K
7 May 2026BuyJohn G. StrattonDirectorDirectorBuy2,000$174K
27 Apr 2026BuyDaniel J. StarksDirectorDirectorBuy10,000$927K
23 Apr 2026BuyPhilip P. BoudreauEVP and CFOEVP and CFOBuy2,200$201K
2 Mar 2026SaleLouis H. MorroneExecutive Vice PresidentExecutive Vice PresidentSale1,144$132K
2 Mar 2026SaleDaniel Gesua Sive SalvadoriEVP and Group PresidentEVP and Group PresidentSale885$102K
2 Mar 2026SaleEric ShroffSenior Vice PresidentSenior Vice PresidentSale709$82K
2 Mar 2026SaleMary K. MorelandExecutive Vice PresidentExecutive Vice PresidentSale613$71K

Showing 10 of 15 trades

Source: SEC insider transactions data sets, Abbott Laboratories' Form 4 filings

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 20 Oct 2023 to 20 Oct 2026

29 people disclosed 56 purchases and 69 sales of Abbott Laboratories stock since October 2023.

DateMember or officialTypeAmount
18 Sep 2026Gilbert Cisneros (House, D-CA)House, D-CA 路 BoughtPurchase$1,001 to $15,000$1K to $15K
4 Sep 2026Rohit Khanna (House, D-CA)House, D-CA 路 BoughtPurchase$1,001 to $15,000$1K to $15K
31 Jul 2026Donald J Trump (President)President 路 BoughtPurchase$100,001 to $250,000$100K to $250K
30 Jul 2026Richard Dean McCormick (House, R-GA)House, R-GA 路 SoldSale$1,001 to $15,000$1K to $15K
17 Jul 2026Donald J Trump (President)President 路 SoldSale$1,001 to $15,000$1K to $15K
17 Jul 2026Mike Kelly (House, R-PA)House, R-PA 路 SoldSale$1,001 to $15,000$1K to $15K
14 Jul 2026Richard W. Allen (House, R-GA)House, R-GA 路 SoldSale$15,001 to $50,000$15K to $50K
8 Jul 2026Rick Larsen (House, D-WA)House, D-WA 路 SoldSale$1,001 to $15,000$1K to $15K
23 Jun 2026Donald J Trump (President)President 路 SoldSale$1,001 to $15,000$1K to $15K
18 Jun 2026Donald J Trump (President)President 路 SoldSale$250,001 to $500,000$250K to $500K

Showing 10 of 125 trades

Source: House, Senate and OGE disclosures via the Congress trading monitor

WARN layoff notices

Notices filed under Abbott Laboratories' own name. Subsidiaries that file under their own names are not included.

Notices from 26 Oct 2023 to 26 Oct 2026

Abbott Laboratories filed 1 notice covering 195 workers since October 2023.

NoticePlaceWorkersEffective
19 Mar 2024CA19518 May 2024

Source: State WARN notices via the US layoffs tracker